Provided by Tiger Fintech (Singapore) Pte. Ltd.

Janux Therapeutics, Inc.

25.94
-0.2700-1.03%
Post-market: 25.940.00000.00%17:59 EDT
Volume:581.92K
Turnover:15.13M
Market Cap:1.54B
PE:-19.00
High:27.00
Open:26.92
Low:25.47
Close:26.21
Loading ...

BRIEF-Janux Therapeutics Q4 Basic EPS USD -0.36

Reuters
·
28 Feb

Janux Therapeutics, Inc. (JANX): Among the Oversold Biotech Stocks to Buy Now

Insider Monkey
·
25 Feb

Analysts Are Bullish on Top Healthcare Stocks: Janux Therapeutics Inc (JANX), Sun Pharmaceutical Industries Limited (IN:SUNPHARMA)

TIPRANKS
·
04 Feb

Janux Therapeutics Promotes Zachariah McIver to Chief Medical Officer

MT Newswires Live
·
25 Jan

Janux Therapeutics names Zachariah McIver, D.O., Ph.D. as Chief Medical Officer

TIPRANKS
·
25 Jan

Janux Therapeutics Promotes Zachariah Mciver, D.o., Ph.d. to Chief Medical Officer

THOMSON REUTERS
·
25 Jan

Janux Therapeutics Promotes Zachariah McIver, D.O., Ph.D. to Chief Medical Officer

Business Wire
·
25 Jan

Buy Rating for Janux Therapeutics Amidst Competitive Landscape and Advancements in Masked T-cell Engagers

TIPRANKS
·
09 Jan

Vir Biotechnology, Once a Hot Covid Stock, Finds New Path Forward in Cancer -- Barrons.com

Dow Jones
·
09 Jan

Janux Therapeutics CEO sells $1.4M in common stock

TIPRANKS
·
30 Dec 2024

LifeSci Capital Initiates a Buy Rating on Janux Therapeutics Inc (JANX)

TIPRANKS
·
27 Dec 2024

Stock Track | Janux Therapeutics Soars 5.08% as BTIG Maintains Buy Rating

Stock Track
·
10 Dec 2024

BTIG Sticks to Its Buy Rating for Janux Therapeutics Inc (JANX)

TIPRANKS
·
10 Dec 2024

Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX) and Kura Oncology (KURA)

TIPRANKS
·
08 Dec 2024

BRIEF-Janux Therapeutics Closes Public Offering For Proceeds Of $402.5 Mln

Reuters
·
07 Dec 2024

Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $402.5 Million

THOMSON REUTERS
·
07 Dec 2024

Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $402.5 Million

Business Wire
·
07 Dec 2024

BUZZ-Janux Therapeutics notches fresh record after $350 mln equity raise

Reuters
·
05 Dec 2024

Bank of America Securities Gives a Buy Rating to Janux Therapeutics Inc (JANX)

TIPRANKS
·
05 Dec 2024

Janux Therapeutics Inc (JANX) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
05 Dec 2024